Evidence map›Paper›PMID 40956349›Full record

ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2025

A pain from the nose to the head: neurological commitment during long COVID.

Laura Cardoso Corrêa-Dias, Ágata Lopes-Ribeiro, Gabriel Eduardo Ribeiro Mendes, Geovane Marques-Ferreira, Caio Wilker-Teixeira, Felipe Alves Clarindo, Victor de Melo Rocha, Maria Eduarda Martuchele-Félix, Henrique Morais Retes, Thaiza Aline Pereira Santos and 14 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Laura Cardoso Corrêa-DiasLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Ágata Lopes-RibeiroLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Gabriel Eduardo Ribeiro MendesLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Geovane Marques-FerreiraLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Caio Wilker-TeixeiraLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Felipe Alves ClarindoLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Victor de Melo RochaLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Maria Eduarda Martuchele-FélixLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Henrique Morais RetesLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Thaiza Aline Pereira SantosLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Gabriela Lorrany Aparecida AzevedoLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Verônica Evelyn Viana PereiraLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Thais de Fátima Silva MoraesLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Erik Vinicius de Sousa ReisLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Letícia Gomes-de-PontesLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Lívia Frota RabeloFundação Hospitalar do Estado de Minas Gerais, Hospital Eduardo de Menezes, Belo Horizonte, Brazil.
Eduardo Augusto Sartori Dos SantosLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Carlos Lorran Dias PereiraLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Fernanda Daniela Santos CoelhoLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Rafael Pacheco CoelhoLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Raiany Araújo SantosLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Gabriel Pacheco CoelhoLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Flávio Guimarães da FonsecaLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Jordana Grazziela Alves Coelho-Dos-ReisLong COVID Study Group, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. jreis@icb.ufmg.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong COVID is a debilitating illness with multi-systemic symptoms that affects at least 10% of individuals who have had COVID-19. Symptoms include respiratory, dermatological, gastrointestinal, cardiovascular, and most frequently reported, neurological sequelae. The most common neurological manifestations include fatigue, brain fog, memory issues, attention disorder, and headaches.

methodsIn this review, we explore the current literature and highlight key findings regarding not only the clinical presentations of neurological commitment during long COVID but mainly the mechanisms that culminate in neuroinflammation, such as autoimmunity, viral reservoirs, and lack of surveillance of T-cells.

resultsNeuroinflammation is a complex multicellular response that directly impacts microglial cells and includes inflammasome activation, trafficking of immune cells, and increased circulating autoantibodies, cytokines, and chemokines in the central nervous system, directly impacting the tissue homeostasis. This review provides important information beyond the clinical manifestations of long COVID. Here, we highlight multifactorial neuroinflammation as the main mechanism involved in long COVID, bringing together several studies that address the different mechanisms that culminate in inflammation of the central nervous system, and highlight possible biomarkers involved in this syndrome and potential therapeutic approaches that have been studied.

conclusionThus, this review strengthens research into long COVID and provides new possibilities for future studies.

Indexed as

COVID-19Neuroinflammatory DiseasesHumansPost-Acute COVID-19 SyndromeSARS-CoV-2COVID-19InflammationLong COVIDSARS-CoV-2Virus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.